fda and semaglutide Compounded is not the same as FDA-approved. The has documented dosing errors hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before The FDA approved a pill

Introduction Binge eating involves consuming an abnormally large amount of food in a short period of time, accompanied by a feeling of loss of control

It is less potent than injectable agents but may be appropriate for patients who cannot tolerate or access injectable therapies

Regul Pept (1996) 63:1722

MAXIMUM RESULTS Starting at $250/month Targets BOTH GLP-1 and GIP receptors Average 2022% body weight loss (SURMOUNT trial data) Once-weekly subcutaneous injection Stronger insulin sensitivity benefit Often greater appetite suppression Compounded by licensed 503A pharmacy Patients seeking maximum weight loss results, those with insulin resistance or pre-diabetes, or anyone who didn't respond optimally to semaglutide alone